Sign in with Google
bullish
Telix Pharmaceuticals (TLX AU): Record Performance in 2024; Robust Forecast for 2025
758 Views24 Feb 2025 00:30
SUMMARY
- Telix Pharmaceuticals (TLX AU) reported 2024 revenue of A$783M, up 56% YoY, beating full year revised guidance of A$745–776M, driven by Illuccix. 2024 R&D expenditure was in-line with guidance.
- Telix provides 2025 revenue guidance of A$1.18–1.23B ($770–800M), up 51–57% YoY. The company expects 2025 R&D expenses to increase 20–25% YoY to A$234–243M.
- 2025 will be a pivotal year for Telix, with three new products launches planned for this year in the U.S. (Zircaix, Pixclara, and Gozellix) and the European/UK rollout of Illuccix.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- East Buy Holdings (1797 HK): Potential KWEB Deletion in June
- [Japan Activism] ISS Comes Out Supporting Orbis Against Tsuruha/Welcia Merger Ratio
- [Japan M&A] NTT (9432) Overpays To Buy Out NTT Data (9613) Minorities
- Laopu Gold (6181 HK): Heritage Luxury, Guochao Appeal. Key Facts, Financials & Valuation
- StubWorld: Geely Is (Mostly) Trading "Rich"; And May Still Bump Zeekr Terms
Top Unpaywalled Insights
More »- The Polycrisis Era (2025–2028): Navigating a World of Overlapping Disruptions
- Our AI-Powered Accounting Risk Trading Strategy Beat the S&P 500 by 2.5x
- India-UK Free Trade Agreement: A New Era for India's Textile Industry
- The Rise of Quant Investing in Crypto w/ Truvius CEO Connor Farley | The New Barbarians #007
- New Research: Unlocking Quantitative Alpha in Cryptocurrency Markets
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Telix Pharmaceuticals (TLX AU): Record Performance in 2024; Robust Forecast for 202524 Feb 2025
- Telix Pharmaceuticals (TLX AU): Pipeline Progress to Expand Portfolio; Favorable Payment Rule in US02 Dec 2024
- Telix Pharmaceuticals (TLX AU): Illuccix Continues to Drive Growth in 1H24; More Products to Come26 Aug 2024
- Telix Pharmaceuticals (TLX AU): Fund Raising Via Convertible Debentures Amid Strong Business Outlook24 Jul 2024
x